A federal judge has paused litigation that Louisiana brought over an abortion drug called mifepristone while the Food and Drug Administration reviews the drug’s safety.
U.S. District Judge David Joseph of Louisiana said in an April 7 order that he is siding with the government and putting the case on hold.
“The equities and the public interest weigh heavily in favor of FDA completing the job that the law requires it to do,” Joseph said in a 37-page ruling.
“Put differently, at this juncture, it is the completion of FDA’s promised good faith, evidence-based, and expeditious review of the mifepristone [review], not ‘government by lawsuit,’ that this Court finds to be in the public interest.”…